Shamudheen Rafiyath

Summary

Publications

  1. pmc Recent advances and novel agents for gastrointestinal stromal tumor (GIST)
    Gurpreet Lamba
    Division of Oncology Hematology, New York Medical College and Westchester Medical Center, Valhalla, NY 10595, USA
    J Hematol Oncol 5:21. 2012
  2. pmc Comparison of safety and toxicity of liposomal doxorubicin vs. conventional anthracyclines: a meta-analysis
    Shamudheen M Rafiyath
    Division of Hematology and Oncology, New York Medical College and Westchester Medical Center, Valhalla, NY 10595, USA
    Exp Hematol Oncol 1:10. 2012
  3. pmc First-line treatment for chronic myeloid leukemia: dasatinib, nilotinib, or imatinib
    Guoqing Wei
    Bone Marrow Transplantation Center, First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, PR China
    J Hematol Oncol 3:47. 2010

Detail Information

Publications3

  1. pmc Recent advances and novel agents for gastrointestinal stromal tumor (GIST)
    Gurpreet Lamba
    Division of Oncology Hematology, New York Medical College and Westchester Medical Center, Valhalla, NY 10595, USA
    J Hematol Oncol 5:21. 2012
    ..A series of investigations and trials are underway to develop novel and effective ways to treat patients with GIST. In this review, we discuss the highlights of recent advances and novel agents for GIST therapy...
  2. pmc Comparison of safety and toxicity of liposomal doxorubicin vs. conventional anthracyclines: a meta-analysis
    Shamudheen M Rafiyath
    Division of Hematology and Oncology, New York Medical College and Westchester Medical Center, Valhalla, NY 10595, USA
    Exp Hematol Oncol 1:10. 2012
    ..abstract:..
  3. pmc First-line treatment for chronic myeloid leukemia: dasatinib, nilotinib, or imatinib
    Guoqing Wei
    Bone Marrow Transplantation Center, First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, PR China
    J Hematol Oncol 3:47. 2010
    ..This review compares and contrasts the three FDA approved first line TKI agents...